Unraveling the complexity of glioblastoma microenvironment: A comparative study of 3D and 2D cultures in response to combination drug therapy
Brain Research · 2025
DOI: 10.1016/j.brainres.2025.149783 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Brain Research, 2025. Verfasst von Rasoul Rashidi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Science in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Tumor Microenvironment, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services, National Institute for Medical Research Development.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) represents one of the most prevalent and treatment-resistant forms of brain cancer. This investigation explored the therapeutic potential of a combined Erlotinib and Imatinib regimen through experimental studies conducted in both two-dimensional and three-dimensional cell culture systems. Cellular viability and apoptotic responses were evaluated 24- and 48-hours post-treatment utilizing MTT assays and flow cytometry, while gene expression analysis of Bcl-2 and VEGF was performed using qRT-PCR. Furthermore, the scratch assay was employed to assess the impact of drug treatment on cellular migration. Notably, lower drug concentrations were required in 3D cultures due to enhanced cell-cell interactions, resulting in greater cytotoxicity and a marked inhibition of tumor cell proliferation. Significant downregulation of Bcl-2 and VEGF expression was observed, particularly a pronounced reduction in Bcl-2, which correlated with elevated apoptosis rates after 48 h. Furthermore, the apoptotic effect of combination therapy was confirmed, with an increase in death percentage in 48 h-3D treated groups, as expected (*P < 0.05 for monotherapy and ***P < 0.001 for combination). The 3D culture model provided a physiologically relevant context for evaluating oncolytic therapies. These findings support the need for continued investigation through advanced preclinical models and eventual clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, School of Advanced Science in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: r-rashidi@razi.tums.ac.ir.
- Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, T…
- Department of Medical Biotechnology, School of Advanced Science in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: b-negahdari@sina.tums.ac.ir.
Förderung
- Tehran University of Medical Sciences and Health Services
- National Institute for Medical Research Development
Zitieren
APA
Rashidi, R., Hadjighassem, M., & Negahdari, B. (2025). Unraveling the complexity of glioblastoma microenvironment: A comparative study of 3D and 2D cultures in response to combination drug therapy. Brain Research. https://doi.org/10.1016/j.brainres.2025.149783
Vancouver
Rashidi R, Hadjighassem M, Negahdari B. Unraveling the complexity of glioblastoma microenvironment: A comparative study of 3D and 2D cultures in response to combination drug therapy. Brain Research. 2025. doi:10.1016/j.brainres.2025.149783
BibTeX
@article{Rashidi2025,
author = {Rashidi, Rasoul and Hadjighassem, Mahmoudreza and Negahdari, Babak},
title = {Unraveling the complexity of glioblastoma microenvironment: A comparative study of 3D and 2D cultures in response to combination drug therapy},
journal = {Brain Research},
year = {2025},
doi = {10.1016/j.brainres.2025.149783}
}
EUVIMED